Continuous Glucose Monitoring Devices Market Surges with Rising Diabetes Prevalence and Technological Upgrades, 2025-2032

Continuous Glucose Monitoring Devices Market is estimated to be valued at USD 7.81 Bn in 2025 and is expected to reach USD 15.12 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032. The global continuous glucose monitoring (CGM) devices market is experiencing significant growth, fueled by the rising demand for real-time glucose monitoring and the increasing global prevalence of diabetes. The market is further driven by the adoption of advanced CGM technologies and the expanding geriatric population worldwide. However, the high cost of CGM devices and inadequate reimbursement policies remain key challenges that could restrain market growth.

Get Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/57
➤Actionable Insights

● Production capacity of continuous glucose monitoring devices rose by 18% in 2024, fueled by expansions in manufacturing hubs across Asia-Pacific and North America.

● Average selling prices moderated by 3.5% in 2024 due to technological optimizations and economies of scale, making devices more accessible to a broader patient base.

● Import data indicates a 21% surge in device shipments to emerging markets like India and Brazil in 2024, highlighting growing demand beyond traditional high-income countries.

● Use cases have diversified as CGM devices are increasingly integrated in hospital intensive care units and outpatient diabetes management programs, reflecting broader clinical acceptance.

● Micro-level indicators show that wearable CGM sensors with enhanced biocompatibility achieved a 27% market penetration among type 1 diabetes patients in Europe by mid-2024.

❖Market Segment and Regional Coverage

○ By Device Type: Real-Time CGM Devices, Intermittently Scanned CGM Devices, Professional CGM Devices, Implantable CGM Devices, and Others.

○ By End User: Hospitals, Home Care Settings, Ambulatory Care Centers, and Clinics.

○ By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, and Others.

Regional and Country Analysis:

○ North America: U.S. and Canada

○ Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

○ Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe

○ Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific

○ Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA.

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/57

✔Key players

» Dexcom Inc., Abbott Laboratories, Medtronic plc, Senseonics Holdings, Inc., Roche Diabetes Care, Ascensia Diabetes Care, Tandem Diabetes Care, AgaMatrix, Inc., IRIS International Inc., Nemaura Medical Inc., Becton Dickinson and Company, and Ypsomed AG.

» Dexcom and Abbott have notably pursued aggressive go-to-market strategies by expanding partnerships with healthcare providers, resulting in a combined 15% uptick in market penetration in 2024.

» Medtronic focused on enhancing device interoperability with smartphone platforms, which increased user retention and contributed to a 12% uplift in device usage in hospital settings during 2024.

➤Growth factors

✓ Increasing prevalence of diabetes worldwide, with WHO citing over 540 million adults expected to be diabetic by 2025, driving sustained demand for CGM devices.

✓ Technological advancements such as longer sensor wear-time and improved accuracy have reduced patient discomfort and device calibrations, encouraging adoption.

✓ Growing insurance reimbursements and healthcare policies supporting remote patient monitoring have expanded accessibility, especially in North America and Europe.

✓ Collaborative initiatives between device makers and digital health firms are accelerating integration of CGM data into telemedicine platforms, improving personalized diabetes management outcomes.

❖ Market trends

⇨ Shift towards non-invasive and implantable continuous glucose monitoring devices is gaining momentum, with at least 3 new devices receiving regulatory approvals in 2024, improving patient compliance.

⇨ Artificial intelligence (AI)-driven predictive analytics integrated with CGM devices enable proactive detection of hypo- and hyperglycemic events, demonstrated in pilot programs involving over 10,000 patients globally in 2024.

⇨ Emerging markets are witnessing rapid growth due to government health initiatives aimed at increasing diabetes awareness, with regional capacities rising by 25% in APAC in 2024.

⇨ Integration of CGM devices with insulin pumps and closed-loop systems is evolving the landscape of automated diabetes care, with revenue from such hybrid systems expected to grow at a CAGR of 14% through 2032.

✒Key takeaways

→ Device types: Real-time CGM dominates with growing implantable CGM adoption due to enhanced patient comfort and device longevity.

→ End users: Home care settings show fastest growth driven by wearables and remote monitoring capabilities.

→ Applications: Type 1 diabetes remains the largest segment, supported by continuous innovation in sensor accuracy and user interface.

→ Regions: North America leads innovation and reimbursement frameworks facilitating market growth; Asia-Pacific presents significant expansion opportunities fueled by rising diabetic populations and improved healthcare infrastructure.

→ Europe shows stable demand with emphasis on integrated digital health solutions; Latin America is gaining traction with increased governmental focus on chronic disease management.

→ Market dynamics are increasingly influenced by cross-sector collaborations involving digital health and AI, accentuating the scope for business growth and new market opportunities in the Continuous Glucose Monitoring Devices market.

To Purchase This Premium Report, Click Here (Discount of Up to 25%): https://www.coherentmarketinsights.com/insight/buy-now/57

❓ Frequently Asked Questions

1. Who are the dominant players in the Continuous Glucose Monitoring Devices market?

The market is led by established companies such as Dexcom Inc., Abbott Laboratories, and Medtronic plc, which have implemented innovative strategies including product enhancement and strategic partnerships to increase market share.

2. What will be the size of the Continuous Glucose Monitoring Devices market in the coming years?

The market size is projected to grow from USD 7.4 billion in 2025 to USD 15.6 billion by 2032, reflecting a robust CAGR of 11.2%, driven by adoption across various diabetes segments and regions.

3. Which end user industry has the largest growth opportunity?

Home care settings are experiencing the fastest growth, largely due to improved wearable device usability, remote monitoring technologies, and wider reimbursement policies supporting outpatient diabetes care.

4. How will market development trends evolve over the next five years?

Trends point towards increased adoption of non-invasive CGM, AI integration for predictive analytics, and expanded presence in emerging economies facilitated by healthcare digitalization and supportive policies.

5. What is the nature of the competitive landscape and challenges in the Continuous Glucose Monitoring Devices market?

The landscape is marked by intense innovation-focused competition with challenges including regulatory compliance, cost pressures, and evolving reimbursement scenarios that players address through diversification and strategic collaborations.

Author of this Marketing PR:

Ravina Pandya, PR Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.

📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837

About CMI:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.